AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Clinical Trial Results for Verve 101 and Axicab2Gin Silo-Lucial in Cardiovascular Disease and Lymphoma
This chapter discusses the results of two clinical trials, one evaluating Verve 101 for cardiovascular disease and the other evaluating Axicab2Gin Silo-Lucial for relapsed or refractory large B cell lymphoma. Both trials showed significant positive outcomes, leading to updates in product characteristics.